v3.25.2
Consolidated Balance Sheets, Parent - USD ($)
shares in Millions, $ in Millions
Jun. 30, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 1,974 $ 3,022
Restricted cash and cash equivalents 88 107
Accounts receivable    
Customer accounts receivable (net of allowance for credit losses of $203 and $190 as of June 30, 2025 and December 31, 2024, respectively) 2,947 3,116
Other accounts receivable (net of allowance for credit losses of $8 and $6 as of June 30, 2025 and December 31, 2024, respectively) 571 602
Mark-to-market derivative assets 726 843
Inventories, net    
Natural gas, oil, and emission allowances 200 243
Materials and supplies 1,385 1,357
Renewable energy credits 628 797
Other 714 689
Total current assets 9,233 10,776
Property, plant, and equipment (net of accumulated depreciation and amortization of $18,493 and $18,088 as of June 30, 2025 and December 31, 2024, respectively) 21,820 21,235
Deferred debits and other assets    
Nuclear decommissioning trust funds 18,289 17,305
Investments 398 640
Goodwill 420 420
Mark-to-market derivative assets 527 372
Other 2,351 2,178
Total deferred debits and other assets 21,985 20,915
Total assets [1] 53,038 52,926
Current liabilities    
Short term loan agreement 900 0
Long-term debt due within one year 125 1,028
Accounts payable and accrued expenses 3,659 3,943
Mark-to-market derivative liabilities 407 467
Renewable energy credit obligation 806 1,076
Other 359 332
Total current liabilities 6,256 6,846
Long-term debt 7,286 7,384
Deferred credits and other liabilities    
Deferred income taxes and unamortized ITCs 3,348 3,331
Asset retirement obligations 12,679 12,449
Pension and non-pension postretirement benefit obligations 1,763 1,875
Spent nuclear fuel obligation 1,397 1,366
Payables related to Regulatory Agreement Units 4,939 4,518
Mark-to-market derivative liabilities 419 399
Other 1,148 1,219
Total deferred credits and other liabilities 25,693 25,157
Total liabilities [1] 39,235 39,387
Commitments and contingencies (Note 13)
Shareholders' equity    
Common stock (No par value, 1,000 shares authorized, 312 and 313 shares outstanding as of June 30, 2025 and December 31, 2024, respectively) 10,939 11,402
Retained earnings (deficit) 4,779 4,066
Accumulated other comprehensive income (loss), net (2,272) (2,302)
Total shareholders’ equity 13,446 13,166
Noncontrolling interests 357 373
Total equity 13,803 13,539
Total liabilities and equity $ 53,038 $ 52,926
Common stock, shares outstanding (in shares) 312 313
[1] Our consolidated assets include $4,279 million and $4,318 million at June 30, 2025 and December 31, 2024, respectively, of certain VIEs that can only be used to settle the liabilities of the VIE. Our consolidated liabilities include $944 million and $968 million at June 30, 2025 and December 31, 2024, respectively, of certain VIEs for which the VIE creditors do not have recourse to us. See Note 15 — Variable Interest Entities for additional information.